← All Seastar Medical Holding CORP filings

Seastar Medical Holding CORP 8-K filings

NASDAQ
ICU
Seastar Medical Holding CORP
8-K: SeaStar Medical Regains Market Value Compliance but Faces Continued Delisting Risk Due to Low Share Price
SeaStar Medical has regained compliance with Nasdaq's market value rule but remains non-compliant with the minimum bid price rule, requiring a hearing to present a plan for compliance.
NASDAQ
ICU
Seastar Medical Holding CORP
8-K: SeaStar Medical Secures $9 Million in Direct Offering to Bolster Hyperinflammation Solutions
SeaStar Medical has announced a $9 million registered direct offering to a single institutional investor, including common stock, pre-funded warrants, and additional warrants.
NASDAQ
ICU
Seastar Medical Holding CORP
8-K: SeaStar Medical Secures Additional Funding Through Convertible Note Issuance
SeaStar Medical completed an additional closing under its Securities Purchase Agreement, issuing a convertible note and warrants to an institutional investor.
NASDAQ
ICU
Seastar Medical Holding CORP
8-K: SeaStar Medical Secures Additional Funding Through Convertible Note Issuance
SeaStar Medical completed an additional closing under its Securities Purchase Agreement, issuing a convertible note and warrants to an institutional investor.
NASDAQ
ICU
Seastar Medical Holding CORP
8-K: SeaStar Medical Appoints David Green as Chief Financial Officer
SeaStar Medical has appointed David Green as its new Chief Financial Officer, effective January 10, 2024, while Caryl Baron transitions to Vice President of Finance.